A review of studies on the detection of mutated KRAS2 sequences as tumor markers in plasma/serum of patients with gastrointestinal cancer

Annals of the New York Academy of Sciences

Volumn 906, Issue , 2000, Pages 13-16

  Sorenson, George D ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

CONFERENCE PAPER; DIGESTIVE SYSTEM CANCER; GENE MUTATION; GENE SEQUENCE; HUMAN; ONCOGENE K RAS;

EID: 0034055893     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06582.x     Document Type: Conference Paper

References (23)

1. 1. VASIOUKHIN, V., P. ANKER, P. MAURICE, J. LYAUTEY, C. LEDERREY & M. STROUN. 1994. Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. Br. J. Haematol. 86: 774-779.
2. 2. SORENSON, G.D., D.M. PRIBISH, F.H. VALONE, V.A. MEMOLI, D.J. BZIK & S-L. YAO. 1994. Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiol. Biomarkers Prev. 3: 67-71.
3. 3. ANKER, P., F. LEFORT, C. VASIOUKHIN, J. LYAUTEY, C. LEDERREY, X.Q. CHEN, M. STROUN, H.E. MULCAHY & M.J.G. FARTHING. 1997. K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology 112: 1114-1120.
4. 4. DE KOK, J.B., W.W. VAN SOLINGE, T.J. RUERS, R.W. ROELOFS, G.N. VAN MUIJEN, J.L. WILLEMS & D.W. SWINKELS. 1997. Detection of tumour DNA in serum of colorectal cancer patients. Scan. J. Clin. Lab. Invest. 57: 601-604.
5. 5. DILLON, D.A., R. SALEM, D. ANDERSEN, J. MARSH, B. BURTNESS, J.R. EMANUEL, V.H. DOMBI, D. BAUTISTA & J.C. COSTA. 1997. K-ras mutations are DNA tumor markers in serum and plasma of patients with cancer of the colon or pancreas. Abstr. N. Engl. Cancer Soc.: 37.
6. 6. KOPRESKI, M.S., F.A. BENKO, C. KWEE et al. 1997. Detection mutant K-ras DNA in plasma or serum of patients with colorectal cancer. Br. J. Cancer 76: 1293-1299.
7. 7. SORENSON, G.D., D.M. PORTER, R.J. BARTH, V.A. MEMOLI, C.H. RHODES, M. KARAGAS, T.D. TOSTESON & D.J. BZIK. 1997. Detection of mutated KRAS2 sequences in plasma from patients with pancreatic carcinoma in comparison with the CA19-9 assay. J. Int. Soc. Oncodev. Biol. Med. 18: 66.
8. 8. HIBI, K., C.R. ROBINSON, S. BOOKER et al. 1998. Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res. 58: 1405-1407.
9. 9. MULCAHY, H.E., J. LYAUTEY & C. LEDERREY. 1998. A prospective study of K-ras mutations in the plasma of pancreatic cancer patients. Clin. Cancer Res. 4: 271-275.
10. 10. YAMADA, T., S. NAKAMORI, H. OHZATO, S. OSHIMA, T. AOKI, N. HIGAKI, K. SUGIMOTO, K. AKAGI, Y. FUJIWARA, I. NISHISHO, M. SAKON, M. GOTOH & M. MONDEN. 1998. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features. Clin. Cancer Res. 4: 1527-1532.
11. 11. CASTELLS, A., P. PUIG, J. MORA, J. BOADAS, L. BOIX, E. URGELL, M. SOLE, G. CAPELLA, F. LUIS, L. FERNANDEZ-CRUZ, S. NAVARRO & A. FARRE. 1999. K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance. J. Clin. Oncol. 17: 578-584.
12. 12. NAKAMORI, S., J. OKAMI, K. SHIOZAKI, T. YAMADA, A. OHSHIMA, T. AOKI, H. NAGANO, K. DONO, K. UMESHITA, M. SAKON & M. MONDEN. 1999. K-ras gene mutations in plasma DNA are potential prognostic indicators for patients with pancreatic cancer. In Gastrointestinal Cancer: Proceedings of ASCO. Vol. 18, abstr. 252a.
13. 13. THEODOR, L., E. MELZER, M. SOLOGOV, G. IDELMAN, E. FRIEDMAN & S. BAR-MEIR. 1999. Detection of pancreatic carcinoma: diagnostic value of K-ras mutations in circulating DNA from serum. Dig. Dis. Sci. 44: 2014-2019.
14. 14. AIHARA, T., S. NOGUCHI, O. ISHIKAWA, H. FURUKAWA, M. HlRATSUKA, H. OHIGASHI, S. NAKAMORI, M. MONDEN & S. IMAOKA. 1997. Detection of pancreatic and gastric cancer cells in peripheral and portal blood by amplification of keratin 19 mRNA with reverse transcriptase-polymerase chain reaction. Int. J. Cancer 72: 408-411.
15. 15. TADA, M., M. OHASHI, Y. SHIRATORI, T. OKUDAIRA, Y. KOMATSU, T. KAWABE, H. YOSHIDA, R. MACHINAMI, K. KISHI & M. OMATA. 1996. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology 110: 227-231.
16. 16. LONGNECKER, D.S. & P.G. TERHUNE. 1998. What is the true rate of KRAS mutation in carcinoma of the pancreas? Pancreas 17: 323-324.
17. 17. TERHUNE, P.G., D.M. PHIFER, T.D. TOSTESON & D.S. LONGNECKER. 1998. K-ras mutation in focal proliferative lesions of human pancreas. Cancer Epidemiol. Biomarkers Prev. 7: 515-521.
18. 18. YANAGISAWA, A., K. OHTAKE, K. OHASHI, M. HORI, T. KITAGAWA, H. SUGANO & Y. KATO. 1993. Frequent ci-K-ras oncogene activation of mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res. 53: 953-956.
19. 19. FURUYA, N. 1997. Long-term follow-up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice. Gastroenterology 113: 593-598.
20. 20. PRETLOW, T.P., T.A. BRASITUS, N.C. FULTON, C. CHEYER & E.L. KAPLAN. 1993. K-ras mutations in putative preneoplastic lesions in human colon. J. Natl. Cancer Inst. 85: 2004-2007.
21. 21. JEN, J., N. PAPADOPOULOS, K.J. SMITH, S.R. HAMILTON, B. VOGELSTEIN & K.W. KINZLER. 1994. Molecular determinants of dysplasia in colorectal lesions. Cancer Res. 54: 5523-5526.
22. 22. MARTÍNEZ, M.E., T. MALTZMAN, J.R. MARSHALL, J. EINSPAHR, M. REID, R. SAMPLINER, D.J. AHNEN, S.R. HAMILTON & D.S. ALBERTS. 1999. Risk factors for Ki-ras protooncogene mutation in sporadic colorectal adenomas. Cancer Res. 59: 5181-5185.
23. 23. FENOGLIO-PREISER, C.M., R.R. PASCAL & K.H. PERZIN. 1990. Tumors of the intestines. Armed Forces Institute of Pathology. Washington, D.C.